Clive Dix joins taskforce that is leading efforts to find and manufacture a coronavirus vaccine
Clive Dix has been appointed deputy chair of the UK’s Vaccine Taskforce, which is leading efforts to find and manufacture a coronavirus vaccine.
Dix, who is the CEO of the drug discovery company C4X Discovery, has experience as a scientist and managing pharmaceutical companies.
He joins Kate Bingham, who was announced as the taskforce’s chair on 16 May.
“The pursuit of a vaccine for Covid-19 is one of the most important parts of the country’s response to the virus,” Dix said on 4 June. “I look forward to working with Kate, applying all of my knowledge and experience to help the taskforce deliver an effective vaccine.”
Meanwhile, Clare Gardiner has been seconded to the role of director general of the Joint Biosecurity Centre, which is part of the NHS test and trace service for Covid-19, both based at the department of health.
The JBC aims to bring together the UK’s data analysis and epidemiological expertise from across government, industry and academia to help control Covid-19 outbreaks.
Gardiner is currently director of national resilience and strategy at the National Cyber Security Centre and has “extensive experience in government as well as an academic and research background in medical statistics and epidemiology”, according to a government announcement on 5 June.